| Doxycycline use in sexually transmitted infections | Dermatologica Helvetica |  | | 2026 | 4 | 0 |
|
| Enjeux pharmaceutiques autour de la pénicilline G : exemple de la syphilis | Revue médicale suisse | | | 2025 | 19 | 0 |
|
| AI-powered classification and network analysis for knowledge mapping in medicine : a century of neurosyphilis research | BMC Medical research methodology |  | | 2025 | 9 | 11 |
|
| Overview of the Current Penicillin Use for the Treatment of Syphilis in Geneva, Switzerland and the Hospital Management to Prevent Future Shortages | STI & HIV 2025 World Congress | | | 2025 | 5 | 30 |
|
| Broadly potent anti-SARS-CoV-2 antibody shares 93% of epitope with ACE2 and provides full protection in monkeys | The Journal of infection | | | 2023 | 4 | 12 |
|
| Induction of a strong and long-lasting neutralizing immune response by dPreS1-TLR2 agonist nanovaccine against hepatitis B virus | Antiviral research | | | 2023 | 14 | 0 |
|
| Development of an antibacterial nanocomposite hydrogel for human dental pulp engineering | Journal of materials chemistry. B | | | 2020 | 12 | 11 |
|
| Advanced Characterization of Imiquimod-Induced Psoriasis-Like Mouse Model | Pharmaceutics | | | 2020 | 4 | 6 |
|
| Molecular modelling of TLR agonist Pam3CSK4 entrapment in PLA nanoparticles as a tool to explain loading efficiency and functionality | International journal of pharmaceutics | | | 2019 | 5 | 0 |
|
| Innovative drug vehicle for local treatment of inflammatory skin diseases: Ex vivo and in vivo screening of five topical formulations containing poly(lactic acid) (PLA) nanoparticles | European journal of pharmaceutics and biopharmaceutics | | | 2017 | 10 | 0 |
|
